MétaCan
Menu
Back to cohort
Record W4317776104 · doi:10.1200/jco.22.01978

Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival

2023· article· en· W4317776104 on OpenAlexafffund
Josephine Lopes Cardozo, Irene L. Andrulis, Stig E. Bojesen, Thilo Dörk, Diana Eccles, Peter A. Fasching, Maartje J. Hooning, Renske Keeman, Heli Nevanlinna, Emiel J. Rutgers, Douglas F. Easton, Per Hall, Paul D.P. Pharoah, Laura van ‘t Veer, Marjanka K. Schmidt, Thomas U. Ahearn, Hoda Anton‐Culver, Volker Arndt, Paul L. Auer, Annelie Augustinsson, Laura E. Beane Freeman, Heiko Becher, Matthias W. Beckmann, Sabine Behrens, Javier Benı́tez, Marina Bermisheva, Carl Blomqvist, Manjeet K. Bolla, Bernardo Bonanni, Terry Boyle, Hermann Brenner, Sara Y. Brucker, Thomas Brüning, Barbara Burwinkel, Saundra S. Buys, Nicola J. Camp, Federico Canzian, Fátima Cardoso, Jose E. Castelao, Melissa H. Cessna, Tsun Leung Chan, Jenny Chang‐Claude, Georgia Chenevix‐Trench, Ji‐Yeob Choi, Sarah V. Colonna, Ellen Copson, Fergus J. Couch, Angela Cox, Simon S. Cross, Kamila Czene, Mary B. Daly, Joe Dennis, Peter Devilee, Caroline A. Drukker, Alison M. Dunning, Miriam Dwek, A. Heather Eliassen, Christoph Engel, D. Gareth Evans, Jonine D. Figueroa, Olivia Fletcher, Henrik Flyger, Manuela Gago-Domínguez, Montserrat García‐Closas, José Á. García-Sáenz, Jeanine M. Genkinger, Graham G. Giles, Anna González‐Neira, Pascal Guénel, Melanie Gündert, Eric Hahnen, Christopher A. Haiman, Niclas Håkansson, Ute Hamann, Mikael Hartman, Bernadette A. M. Heemskerk‐Gerritsen, Alexander Hein, Weang-Kee Ho, Reiner Hoppe, John L. Hopper, Richard S. Houlston, Anthony Howell, David J. Hunter, Hidemi Ito, Anna Jakubowska, Helena Jernström, Esther M. John, Nichola Johnson, Michael E. Jones, Joseph Vijai, Rudolf Kaaks, Daehee Kang, Sung-Won Kim, Cari M. Kitahara, Linetta B. Koppert, Veli‐Matti Kosma, Peter Kraft, Vessela N. Kristensen, Katerina Kubelka‐Sabit, Stella Koutros, Allison W. Kurian, Ava Kwong, James V. Lacey, Diether Lambrechts, Loı̈c Le Marchand, Jingmei Li, Jan Lubiński, Michael Lush, Mehdi Manoochehri, Sara Margolin, Keitaro Matsuo, Dimitrios Mavroudis, Kyriaki Michailidou, Roger L. Milne, Nur Aishah Mohd Taib, Anna Marie Mulligan, Patrick Neven, William G. Newman, Nadia Obi, Kenneth Offit, Andrew F. Olshan, Sue K. Park, Tjoung‐Won Park‐Simon, Alpa V. Patel, Dijana Plaseska-Karanfilska, Coralie Poncet, Ross L. Prentice, Nadège Presneau, Renate Prevos, Katri Pylkäs, Paolo Radice, Gad Rennert, Hedy S. Rennert, Atocha Romero, Emmanouil Saloustros, Elinor J. Sawyer, Rita K. Schmutzler, Lukas Schwentner, Christopher G. Scott, Mitul Shah, Chen‐Yang Shen, Xiao‐Ou Shu, Xueling Sim, Melissa C. Southey, Jennifer Stone, Daniel O. Stram, Rulla M. Tamimi, Soo‐Hwang Teo, Lauren R. Teras, Mary Beth Terry, Katarzyna Tomczyk, Ian Tomlinson, Melissa A. Troester, Thérèse Truong, Celine M. Vachon, Chantal Van Ongeval, Qin Wang, Barbara Wappenschmidt, Camilla Wendt, Robert Winqvist, Alicja Wolk, Anna H. Wu, Siddhartha Yadav, Cheng Har Yip, Wei Zheng, Argyrios Ziogas

Bibliographic record

VenueJournal of Clinical Oncology · 2023
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBRCA gene mutations in cancer
Canadian institutionsLunenfeld-Tanenbaum Research InstituteUniversity of TorontoMount Sinai Hospital
FundersMedical Research and Materiel CommandNational Institute on AgingServicio Gallego de SaludInstitute of Biomedical Sciences, Academia SinicaInstituto de Salud Carlos IIICancer Council Western AustraliaCancer Council NSWCancer Council VictoriaWorld Cancer Research FundMedical Research CouncilManchester Biomedical Research CentreDivision of Cancer Prevention, National Cancer InstituteNational Institutes of HealthHellenic Health FoundationUniversitätsklinikum Hamburg-EppendorfXunta de GaliciaRheinische Friedrich-Wilhelms-Universität BonnMutuelle Générale de l'Education NationaleImperial Experimental Cancer Medicine CentreInstitut Gustave-RoussyCenter for Agroforestry, University of MissouriOulun YliopistoNational Health and Medical Research CouncilMinistry of Education, Science and TechnologyAcademia SinicaDeutsche KrebshilfeNational Institute for Health and Care ResearchCenters for Disease Control and PreventionCancer Council South AustraliaMemorial Sloan-Kettering Cancer CenterCentre International de Recherche sur le CancerKreftforeningenInstitut National Du CancerSanofiLeids Universitair Medisch CentrumKarolinska InstitutetAssociazione Italiana per la Ricerca sul CancroKWF KankerbestrijdingSyöpäsäätiöVetenskapsrådetNational Medical Research CouncilNorges ForskningsrådStockholms Läns LandstingUniversity of WestminsterLigue Contre le CancerCalifornia Department of Public HealthNational Research Foundation of KoreaKorea Health Industry Development InstituteJapan Agency for Medical Research and DevelopmentDeutsche Gesetzliche UnfallversicherungKing's College LondonGentofte HospitalUniversity of Southern CaliforniaCancerfondenAmerican Cancer SocietyCancer AustraliaRussian Foundation for Basic ResearchKuopion Yliopistollinen SairaalaErasmus Universiteit RotterdamNational Heart, Lung, and Blood InstituteUniversiteit LeidenUniversity of CreteInstitut National de la Santé et de la Recherche MédicaleAgency for Science, Technology and ResearchCanadian Institutes of Health ResearchEuropean CommissionEuropean Organisation for Research and Treatment of CancerCancer Institute NSWKerry Group Kuok FoundationStavros Niarchos FoundationFondation de FranceNational Research FoundationNIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer ResearchUniversity of UtahBreast Cancer CampaignNational Breast Cancer FoundationAgence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du TravailNational Institute of Environmental Health SciencesSwedish Cancer FoundationProgramme Grants for Applied ResearchRobert Bosch StiftungHarvard T.H. Chan School of Public HealthHuntsman Cancer FoundationUniversity of California, San FranciscoIntermountain HealthcareConsejo Nacional de Ciencia y TecnologíaSundhed og Sygdom, Det Frie ForskningsrådNational Center for Chronic Disease Prevention and Health PromotionUnicancerDeutsches KrebsforschungszentrumNational Research Foundation SingaporeAcademy of FinlandJames S. McDonnell FoundationAgence Nationale de la RechercheWellcome TrustFondation du cancer du sein du QuébecBrigham and Women's HospitalU.S. Department of DefenseCancer Research UKU.S. ArmyMinistry of Science and Higher Education of the Russian FederationEli Lilly and CompanyLon V. Smith FoundationGenome CanadaCancer Council TasmaniaItä-Suomen YliopistoNational Cancer InstituteEuropean Regional Development FundMinisterio de Sanidad, Servicios Sociales e IgualdadGovernment of CanadaUniversity of CambridgeBreast Cancer Research FoundationU.S. Department of Health and Human ServicesNational Cancer Research InstituteF. Hoffmann-La RocheFreistaat SachsenFonds Wetenschappelijk OnderzoekHuntsman Cancer InstituteMinisterio de Economía y CompetitividadBundesministerium für Bildung und ForschungMinistry of Education, Culture, Sports, Science and TechnologyOvarian Cancer Research FundSusan G. Komen for the CureTaiwan Biobank
KeywordsMedicineBreast cancerOncologyInternal medicinePolygenic risk scoreCancerSingle-nucleotide polymorphismGeneGeneticsGenotypeBiology

Abstract

fetched live from OpenAlex

PURPOSE A polygenic risk score (PRS) consisting of 313 common genetic variants (PRS313) is associated with risk of breast cancer and contralateral breast cancer. This study aimed to evaluate the association of the PRS313 with clinicopathologic characteristics of, and survival following, breast cancer. METHODS Women with invasive breast cancer were included, 98,397 of European ancestry and 12,920 of Asian ancestry, from the Breast Cancer Association Consortium (BCAC), and 683 women from the European MINDACT trial. Associations between PRS313 and clinicopathologic characteristics, including the 70-gene signature for MINDACT, were evaluated using logistic regression analyses. Associations of PRS313 (continuous, per standard deviation) with overall survival (OS) and breast cancer–specific survival (BCSS) were evaluated with Cox regression, adjusted for clinicopathologic characteristics and treatment. RESULTS The PRS313 was associated with more favorable tumor characteristics. In BCAC, increasing PRS313 was associated with lower grade, hormone receptor–positive status, and smaller tumor size. In MINDACT, PRS313 was associated with a low risk 70-gene signature. In European women from BCAC, higher PRS313 was associated with better OS and BCSS: hazard ratio (HR) 0.96 (95% CI, 0.94 to 0.97) and 0.96 (95% CI, 0.94 to 0.98), but the association disappeared after adjustment for clinicopathologic characteristics (and treatment): OS HR, 1.01 (95% CI, 0.98 to 1.05) and BCSS HR, 1.02 (95% CI, 0.98 to 1.07). The results in MINDACT and Asian women from BCAC were consistent. CONCLUSION An increased PRS313 is associated with favorable tumor characteristics, but is not independently associated with prognosis. Thus, PRS313 has no role in the clinical management of primary breast cancer at the time of diagnosis. Nevertheless, breast cancer mortality rates will be higher for women with higher PRS313 as increasing PRS313 is associated with an increased risk of disease. This information is crucial for modeling effective stratified screening programs.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.005

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.066
GPT teacher head0.418
Teacher spread0.352 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations28
Published2023
Admission routes2
Has abstractyes

Explore more

Same venueJournal of Clinical OncologySame topicBRCA gene mutations in cancerFrench-language works237,207